Free Account Opening + AMC Free Demat
Loading...

Marksans Pharma Buyback vs Route Mobile Buyback

Comparision between Marksans Pharma Buyback and Route Mobile Buyback.

Buyback Details

Marksans Pharma Buyback is a Open Market Through Stock Exchange buyback proposed to list at BSE, NSE while Route Mobile Buyback is a Open Market Through Stock Exchange proposed to list at BSE, NSE.

  Marksans Pharma Ltd Route Mobile Limited
Logo Marksans Pharma Buyback Logo Route Mobile Buyback Logo
Type of Buyback Open Market Through Stock Exchange Open Market Through Stock Exchange
Listing At BSE, NSE BSE, NSE
Face Value ₹1 per share ₹10 per share
Buyback Price ₹60 per share ₹1700 per share
Issue Size
Issue Size (Amount) ₹60.00 Crores ₹120.00 Crores
Buyback Ratio
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Lead Managers Sundae Capital Advisors Edelweiss Financial Services Ltd
Necessity of the buyback

The buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders.

2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.

The buyback is being undertaken for the following reasons:

1. Utilise the available surplus funds, which are in excess of the surplus amount needed to be retained by the company for future growth over a medium term.

2. The Buyback would help in improving the return on equity, based on the consumption that the company would earn similar profits as in the past and increasing shareholder value in the long term.

Buyback Timetable

Marksans Pharma Buyback and Route Mobile Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Marksans Pharma Buyback Buyback record date is . Route Mobile Buyback Buyback record date is .

  Marksans Pharma Ltd Route Mobile Limited
Record Date
Offer Open Date Jul 15, 2022 Jul 11, 2022
Offer Closure Date Jan 14, 2023 Aug 29, 2022
Last date for receipt of tender forms
Finalisation of buyback
Last Date for settlment of bids
Last Date for extinguishment of shares

Financial Details and Other Relevent Information

Comparison of Marksans Pharma Buyback and Route Mobile Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Marksans Pharma Ltd Route Mobile Limited
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lakhs)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 1,53,269.20 1,38,287.61 1,13,453.67
Profit After Tax 18,681.40 23,853.88 12,075.27
Net Worth 1,04,216.44 86,972.58 61,990.88
Reserves and Surplus 99,623.30 82,379.44 57,397.74
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Crore)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 2,002.09 1,422.16 968.10
Profit After Tax 170.08 132.76 58.20
Net Worth 1,672.57 652.11 269.38
Reserves and Surplus 1,609.70 594.40 219.38
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.70 44.28
May-2022 53.45 44.50 48.20
Apr-2022 62.35 45.55 55.56

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Dec-2021 1920.00 1666.00 1770.14
Jan-2022 1935.00 1480.00 1778.20
Feb-2022 1886.60 1396.00 1632.06
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.60 44.15
May-2022 53.50 44.50 48.23
Apr-2022 62.40 45.50 56.03

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Dec-2021 1923.20 1663.25 1770.46
Jan-2022 1935.60 1480.00 1777.95
Feb-2022 1888.90 1396.00 1631.92

Comments

Add a public comment...